Results 191 to 200 of about 907,835 (284)
Research capacity in Africa—will the sun rise again?
The Lancet Global Health, 2016 Justine Davies, Zoë Mullan
doaj +1 more source
Molecular Oncology, EarlyView.Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq +8 more
wiley +1 more source
Retraction: Unlocking the power of L1 regularization: A novel approach to taming overfitting in CNN for image classification. [PDF]
PLoS OnePLOS One Editors.
europepmc +1 more source
Molecular Oncology, EarlyView.Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park +6 more
wiley +1 more source
Protecting the health of the people
Australian and New Zealand Journal of Public Health, 2003 Jeanne Daly, Judith Lumley
doaj +1 more source
Retraction: Edge computing based english translation model using fuzzy semantic optimal control technique. [PDF]
PLoS OnePLOS One Editors.
europepmc +1 more source
Australian and New Zealand Journal of Public Health, 2002 Jeanne Daly, Judith Lumley
doaj +1 more source
Life Sciences Discovery and Technology Highlights
SLAS TechnologyJamien Lim, Tal Murthy
doaj +1 more source
Public health achievements II: Methodological development
Australian and New Zealand Journal of Public Health, 2004 Jeanne Daly, Judith Lumley
doaj +1 more source
AI in Medical Education Research, Writing, and Reviewing: JGME's Policy in 2026. [PDF]
J Grad Med EducSullivan GM +4 more
europepmc +1 more source